You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-20. All clients entering outpatient treatment: distribution by primary drug at treatment in 2003 for those countries supplying data

Country

Opiates

Cocaine

Stimulants

Hypnotics sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other substances

Czech Republic

32.8

0.3

35.9

2.5

0.4

3.1

24.6

0.4

Denmark

39.6

5.5

9.2

0.0

0.0

0.0

33.8

11.9

Germany

45.4

8.1

8.6

1.5

0.3

0.1

34.8

1.3

Greece

83.9

1.3

0.5

1.4

0.2

0.2

12.6

0.0

Cyprus

60.4

6.1

4.9

1.8

0.0

0.6

25.6

0.6

Latvia

80.2

0.2

7.6

4.3

0.3

5.4

1.7

0.4

Luxembourg

19.4

9.7

22.3

4.9

19.4

0.0

24.3

0.0

Hungary

21.5

1.1

8.8

11.5

0.4

1.6

39.2

16.0

Malta

74.4

7.4

0.7

0.0

0.2

0.0

17.1

0.2

Netherlands

34.7

37.9

4.6

1.4

0.5

0.0

20.3

0.5

Slovenia

88.0

0.8

0.5

0.1

0.0

0.1

10.4

0.0

Slovakia

55.2

0.9

19.5

2.8

0.6

4.7

15.8

0.4

Finland

37.7

0.1

31.8

6.3

0.2

0.1

23.2

0.5

Sweden

31.7

0.9

28.7

10.0

0.1

0.5

26.1

2.1

United Kingdom

71.4

9.5

4.6

2.1

0.1

0.4

10.7

1.2

Bulgaria

95.7

0.7

0.6

0.8

0.0

0.2

1.7

0.2

Romania

68.4

0.5

0.6

21.4

0.2

1.3

2.4

5.3

Source:

2004 Reitox national reports - TDI outpatient treatment centres – see [Table TDI-14]

Data filter | tditab20-en.xml